The Valens Company (TSX: VLNS) (OTCQX: VLNCF) - Investor Dashboard

Summary

Financials (08/31/21)

Capital Structure (10/13/21)

Company Brief

The Valens Company (Follow Company) is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services across five core technologies, in addition to best-in-class product development, formulation and manufacturing of cannabis consumer packaged goods. The Valens Company’s high-quality products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on next-generation product development and innovation.

Its breakthrough patented emulsification technology, SōRSE™ by Valens, converts cannabis oil into water-soluble emulsions for seamless integration into a variety of product formats, allowing for near-perfect dosing, stability, and taste. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the Company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets.

Featured Video

The Valens Company President Jeff Fallows discusses the company’s Verse acquisition and Citizen Stash acquisition.

Highlights

• The largest custom manufacturer of cannabis products in Canada servicing both recreational, medical, and health and wellness markets
• B2B third-party manufacturing and B2C branded sales
• Distributing products to Alberta, British Columbia, Manitoba, Ontario, Saskatchewan, New Brunswick,  Yukon and Québec
• Manufacturing agreements with three of the top seven Canadian LPs by market share
• Proven full commercialization of SKUs in under 45 business days
• Acquisition of Canadian edibles manufacturer, LYF Food Technologies Inc.
• Direct entry into the U.S. market and expanded product offerings in Canada via the Green Roads acquisition
• First ISO 17025 Accredited Lab

Growth Strategy

• Building a diverse IP portfolio that spans across all types of products and services
• Increasing output of Cannabis 2.0 and 3.0 products leveraging SōRSE by Valens technology, and gain market share
• Expand distribution network, target markets and opportunities that maximize ROI, and export globally with EU GMP certification
• Establishing high-value partnerships to position the company as a trusted choice for LPs, brands and CPG companies
• Acquisitions of Verse Cannabis and Citizen Stash position Verse as a top tier Canadian LP
• Enter or expand within select international markets, including the U.S., Mexico, Central America, South America, Europe, Australia and Japan

Differentiators

• Developing the future of cannabis consumption
• Building a diverse IP portfolio spanning all types of products and services
• Holds five core proprietary cannabis processing technologies at its K2 facility in Kelowna, British Columbia – the most in Canada
• Largest third-party vape manufacturer in Canada
• Strong R&D and innovation platform
• Valens Labs, research and testing facility, Named a “Center of Excellence in Plant Based Science” by ThermoFisher Scientific

Desjardins Securities

M Partners

Raymond James